vimarsana.com

Page 155 - மருத்துவ அவசர ஊர்தி புதியது தெற்கு வேல்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rep Ocasio-Cortez, allies move to court establishment, not fight it

Leading progressives like Rep. Alexandria Ocasio-Cortez, D-N.Y., had a choice after they won election in 2018 and expanded their ranks in 2020: challenge Democratic leaders from the sidelines, or get in the game. Now their decision to play by Congress’ rules is giving them clout in a government under unified Democratic control with President Joe Biden. Members of Rep. Ocasio-Cortez’s so-called Squad are taking leadership roles in the House and building experience on Capitol Hill, turning them into not just ideological purists but also strategic legislators. They’re gently pushing a bolder Democratic strategy and meeting regularly with White House aides, bringing liberal dreams like a $15 federal minimum wage and a permanent child tax credit within reach.

Welcome To IANS Live - SCIENCE - Antipsychotics can lower Covid infection, severity risk: Study

Photo Credit: IANS IANSLive London, April 12 (IANS) Patients treated with antipsychotic drugs have a lower risk of becoming infected or suffer a milder form of SARS-CoV-2 the virus causing Covid-19 if they get infected, according to a study. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 12-April-2021

Applied DNA Sciences, Inc and Takis Biotech/Evvivax: Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA COVID-19 Vaccine Candidate in Felines

Applied DNA Sciences, Inc. and Takis Biotech/Evvivax: Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA COVID-19 Vaccine Candidate in Felines - Strong Neutralizing Antibody Titer Elicited Across Cohort - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company ), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. ( Evvivax ), today announced positive preliminary Phase I clinical trial results for a LinearDNA COVID-19 vaccine candidate (the vaccine candidate ) in adult domestic felines. Results following administration of a single prime dose of the vaccine candidate on day 1 in late February indicate that the LinearDNA vaccine candidate is well-tolerated by the cohort. A SARS-CoV-2 neutralization assay was conducted by the Cornell University Animal Health Diagnostic Center at the College of Veterinary Medicine 20 days after prime dose delivery

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.